Evidence map›Paper›PMID 38964923›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Clinicopathologic characteristics and survival analysis of primary large B-cell lymphoma of the central nervous system].

Q F Xu, R Shen, Y G Shen, Y W Cao, Y Qian, P P Xu, S Cheng, L Wang, W L Zhao

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Q F XuDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
R ShenDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Y G ShenDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Y W CaoDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Y QianDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
P P XuDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
S ChengDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
L WangDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
W L ZhaoDepartment of Haematology, State Key Laboratory of Medical Genomics, Shanghai Institute of Haematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Funding

Major Clinical Research Project of Shanghai Hospital Development Centre SHDC2020CR1032B, SHDC2022CRD033Multicentre Clinical Research Project of Shanghai Jiao Tong University School of Medicine DLY201601National Key Research and Development Program of China 2022YFC2502600National Natural Science Foundation of China 81830007, 82130004, 82170178, 82200201, 82070204'Peak' Grant Support Foundation for Clinical Medicine of Shanghai Municipal Education Commission 20152206, 20152208
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Central Nervous System NeoplasmsFemaleHumansLymphoma, Large B-Cell, DiffuseMaleMiddle AgedPrognosisProportional Hazards ModelsRemission InductionRetrospective StudiesSurvival AnalysisSurvival RateBruton tyrosine kinaseCentral nervous systemLymphoma, large B-cell, diffuseMutationPrognosis

Identifiers

PMID38964923
PMCPMC11270494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.